Yubo International Biotech Limited
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.1M | $-1.8M | $-1.2M | $-1.2M | $-1.5M | $-711.8K | $-148.0K | $-144.0K |
| Depreciation & Amortization | $167.6K | $169.9K | $178.3K | $18.1K | $13.2K | $13.1K | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $10.2K | $13.4K | $11.7K | $9.4K | $8.2K | $4.1K | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-842.8K | $-1.3M | $-739.0K | $-601.0K | $-1.0M | $101.1K | $-32.0K | $-55.0K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | $0 | $564.7K | $42.6K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $118.4K | $0 | $-39.8K | $-564.7K | $-97.5K | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $849.5K | $1.4M | $745.7K | $669.2K | $127.2K | $1.4M | $34.0K | $56.0K |
| Net Change in Cash | $1.0K | $656 | $-11.9K | $-9.3K | $-1.4M | $-1.0K | $2.0K | $1.0K |
| Free Cash Flow | — | — | — | $-601.0K | $-1.6M | $58.6K | — | — |